+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prevalence, outcome and risk factor associated with vancomycin-resistant Enterococcus faecalis and Enterococcus faecium at a Tertiary Care Hospital in Northern India



Prevalence, outcome and risk factor associated with vancomycin-resistant Enterococcus faecalis and Enterococcus faecium at a Tertiary Care Hospital in Northern India



Indian Journal of Medical Microbiology 34(1): 38-45



To determine the prevalence, genotype, risk factors and mortality in patients having vancomycin-resistant Enterococcus faecalis (VR E. faecalis) and Enterococcus faecium (VR E. faecium) infection or colonisation. A total of 1488 clinical isolates of E. faecalis and E. faecium were tested for vancomycin resistance by phenotypic (disk diffusion, E-test and broth micro-dilution test) and genotypic polymerase chain reaction methods. Records of all 1488 patients who had E. faecalis or E. faecium infection or colonisation were reviewed for the identification of host, hospital and medication related risk factors associated with VR E. faecalis and VR E. faecium. Of 1488 isolates, 118 (7.9%) were vancomycin-resistant and their distributions were as follows: E. faecalis=72 (61%) and E. faecium=46 (39%). All 118 vancomycin-resistant isolates were vanA genotype (minimum inhibitory concentration [MIC] to vancomycin ≥64 μg/ml and MIC to teicoplanin≥32 μg/ml) and none of the isolates was vanB genotype. Multivariate logistic regression analysis identified ventilator support and hospital stay for ≥48 h as independent risk factors associated with VR E. faecalis and VR E. faecium infection or colonisation. Hospital stay≥48 h was the only independent risk factor for mortality in patients infected with vancomycin-resistant enterococci. Strategies to limit the nosocomial infection especially in patients on ventilator support can reduce VRE incidence and related mortality.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 058620038

Download citation: RISBibTeXText

PMID: 26776117


Related references

Outbreak of vancomycin-resistant enterococci in a tertiary hospital: the lack of effect of measures directed mainly by surveillance cultures and differences in response between Enterococcus faecium and Enterococcus faecalis. American Journal of Infection Control 38(5): 406-409, 2010

Geographic region as a risk factor for clonality among nosocomial isolates of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis. Abstracts of the General Meeting of the American Society for Microbiology 98: 190, 1998

Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients. Infection Control and Hospital Epidemiology 28(9): 1054-1059, 2007

Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis. Journal of Microbiology, Immunology, and Infection 41(2): 124-129, 2008

Unusual increase of vancomycin-resistant Enterococcus faecium but not Enterococcus faecalis at a university hospital in Taiwan. Chang Gung Medical Journal 30(6): 493-503, 2008

Linezolid resistance in vancomycin-resistant Enterococcus faecalis and Enterococcus faecium isolates in a Brazilian hospital. Antimicrobial Agents and ChemoTherapy 58(5): 2993-2994, 2014

Vancomycin-resistant Enterococcus faecium Bacteremia in a tertiary care hospital: epidemiology, antimicrobial susceptibility, and outcome. Biomed Research International 2014: 958469, 2014

New combinations of mutations in VanD-Type vancomycin-resistant Enterococcus faecium, Enterococcus faecalis, and Enterococcus avium strains. Antimicrobial Agents and ChemoTherapy 53(5): 1952-1963, 2009

Molecular characterization of clinical and environmental isolates of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis from a teaching hospital in Wales. Journal of Medical Microbiology 52(Pt 9): 821-827, 2003

Molecular characterization of resistance, virulence and clonality in vancomycin-resistant Enterococcus faecium and Enterococcus faecalis: A hospital-based study in Beijing, China. Infection Genetics and Evolution 33: 253-260, 2015

Prevalence of high-level gentamicin-resistant Enterococcus faecalis and Enterococcus faecium in an Iranian hospital. Journal of Preventive Medicine and Hygiene 57(4): E197-E200, 2016

Status of high level aminoglycoside resistant Enterococcus faecium and Enterococcus faecalis in a rural hospital of central India. Indian Journal of Medical Microbiology 26(4): 369-371, 2008

Comparative evaluation of penicillin, ampicillin, and imipenem MICs and susceptibility breakpoints for vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis and Enterococcus faecium. Journal of Clinical Microbiology 39(7): 2729-2731, 2001

An outbreak of vancomycin-resistant Enterococcus faecium in a tertiary care hospital. Abstracts of the General Meeting of the American Society for Microbiology 94: 615, 1994

Bacteremia with vancomycin resistant Enterococcus faecium and vancomycin sensitive Enterococcus faecium Comparison of epidemiology and clinical outcome. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 33: 275, 1993